Kennedy Capital Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $163K | Buy |
65,875
+2,352
| +4% | +$5.83K | ﹤0.01% | 573 |
|
2025
Q1 | $98.5K | Sell |
63,523
-370,270
| -85% | -$574K | ﹤0.01% | 637 |
|
2024
Q4 | $928K | Sell |
433,793
-223,243
| -34% | -$478K | 0.02% | 601 |
|
2024
Q3 | $2.86M | Sell |
657,036
-46,247
| -7% | -$201K | 0.06% | 437 |
|
2024
Q2 | $3.28M | Sell |
703,283
-13,900
| -2% | -$64.8K | 0.07% | 427 |
|
2024
Q1 | $3.64M | Sell |
717,183
-23,718
| -3% | -$120K | 0.07% | 396 |
|
2023
Q4 | $2.08M | Sell |
740,901
-9,391
| -1% | -$26.4K | 0.05% | 485 |
|
2023
Q3 | $2.15M | Sell |
750,292
-1,111
| -0.1% | -$3.19K | 0.05% | 446 |
|
2023
Q2 | $3.79M | Buy |
+751,403
| New | +$3.79M | 0.09% | 351 |
|